Skip to main content
. 2020 Aug 31;20(5):182. doi: 10.3892/ol.2020.12043

Figure 1.

Figure 1.

Typical immunohistochemical images of SLC17A9 expression in cancer tissues of HCC patients (×400). (A) Low expression of SLC17A9 in cancer tissues (n=43). (B) High expression of SLC17A9 in cancer tissues (n=55). SLC17A9, solute carrier family 17 member 9; HCC, hepatocellular carcinoma.